FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended to detect precancerous changes in the mammary gland. In the supernatant, samples of patient's blood cells incubated with cancer-embryonic antigen (CEA) and without CEA determine the concentration of IL-1β. Calculate the index of influence (IV) CEA on the production of IL-1β according to the formula. With the value of IV REA IL-1β, not exceeding 13, reveal precancerous changes in the breast (sclerosing adenosis or proliferates of the breast).
EFFECT: invention provides a highly sensitive and specific method for detecting precancerous changes in the mammary gland.
1 cl, 1 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRECANCEROUS CHANGES IDENTIFICATION IN MAMMARY GLAND | 2016 |
|
RU2623857C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF INVASIVE DUCTAL CANCER AND MAMMARY GLAND FIBROADENOMA | 2015 |
|
RU2613879C1 |
| METHOD FOR DETECTING EPITHELIAL DYSPLASIA OF GASTRIC MUCOSA IN PATIENTS SUFFERING ATROPHIC GASTRITIS OR GASTRIC ADENOMA | 2014 |
|
RU2560703C1 |
| METHOD FOR DETECTION OF EPITHELIAL DYSPLASIA OF GASTRIC MUCOSA IN ATROPHIC CHANGES | 2015 |
|
RU2584750C1 |
| BREAST CYST FORMATIONS CLASSIFICATION | 2017 |
|
RU2639804C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR MALIGNANT AND BENIGN BREAST PATHOLOGY | 2013 |
|
RU2530557C1 |
| METHOD FOR DIAGNOSING BREAST CANCER BY THE LEVEL OF METHYLATION OF THE ZNF177 AND CCDC181 GENES IN SMALL TUMORS | 2022 |
|
RU2789200C1 |
| METHOD FOR DETERMINING CALCITONIN AND CANCER-EMBRYO ANTIGEN IN PUNCTATE FOCAL LIVER FORMATION | 2020 |
|
RU2736693C2 |
| METHOD FOR DIAGNOSTICS AND TREATMENT OF OBLIGATE PRECANCER DISEASES AND CA IN SITU | 2021 |
|
RU2794856C2 |
| AGENT INDUCING PRODUCTION OF INTERLEUKIN-8 | 2019 |
|
RU2712785C1 |
